More on TNGX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-142.9% Growth)
- Ratings (9.3 Score)

Upcoming Events

- Earnings (11/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Tango Therapeutics, Inc (NQ:TNGX)
Delayed: 22.52 -0.24 (1.05%)
Prev. Close $22.76  
Open$22.48 
52 Wk High$ 
52 Wk Low$ 
Day High$22.94 
Day Low$22.29 
P/E N/A  
EPS$ 
Volume1,457,380 

Friends, Peers and Foes (?): ABBV, ONCY, TEVA, NUVL, PRAX (more...)

Sep 3, 2026 04:05 PM Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 1, 2026 07:00 AM Tango Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
Aug 18, 2026 06:39 AM Tango Therapeutics Inc. (TNGX) PT Raised to $68 at H.C. Wainwright
Aug 17, 2026 07:49 AM Tango Therapeutics Inc. (TNGX) Reiterated at Buy by Stifel: 3 Catalysts by YE26
Aug 14, 2026 04:49 PM Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Nextech Crossover I GP S.a r.l.
Aug 14, 2026 04:20 PM Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: TCG Crossover GP II, LLC
Aug 14, 2026 02:12 PM Form SCHEDULE 13G Tango Therapeutics, Inc. Filed by: GOLDMAN SACHS GROUP INC
Aug 14, 2026 11:05 AM Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Woodline Partners LP
Aug 14, 2026 08:24 AM Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: FARALLON CAPITAL MANAGEMENT, L.L.C.
Aug 12, 2026 12:02 PM Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Adage Capital Management, L.P.
View All Articles

Entities mentioned with TNGX

View All Entities